$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
Can larotrectinib treat small cell lung cancer?
2025-10-19 11:44:20
Check Details
The effect of crizotinib in the treatment of ALK-positive non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How effective is the neoadjuvant drug nivolumab monotherapy in the treatment of lung cancer
2025-10-19 11:44:20
Check Details
Is the anti-cancer drug larotrectinib included in medical insurance? How much does a box cost?
2025-10-19 11:44:20
Check Details
Can lung squamous cell carcinoma without mutations be treated with afatinib?
2025-10-19 11:44:20
Check Details
Is afatinib a second-line treatment for lung squamous cell carcinoma?
2025-10-19 11:44:20
Check Details
The efficacy of nivolumab combined with ipilimumab in the treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
What patients with lung cancer need to know about using larotrectinib
2025-10-19 11:44:20
Check Details
Afatinib is the first oral targeted drug for lung squamous cell carcinoma approved by the FDA_ Kanghule
2025-10-19 11:44:20
Check Details
The broad-spectrum anti-tumor drug larotrectinib is applicable to the population, usage and dosage
2025-10-19 11:44:20
Check Details
How effective is nivolumab in the treatment of advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Afatinib can effectively improve the survival of patients with lung squamous cell carcinoma_ Kanghule
2025-10-19 11:44:20
Check Details
1
2
...
9908
9909
9910
9911
9912
9913
9914
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
2
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
3
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor
4
Is Eplerenone Suitable for Long-Term Use?
5
Does Ixazomib (Ninlaro) Require Long-Term Use to Be Effective?
6
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
7
What is the effectiveness of the new weapon for myeloma patients: cetuximab? Listen to what the user has to say
8
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
9
What diseases can Upatinib be used for? Which patients are suitable for use?
10
The efficacy of Eltrombopag
11
User Agreement
12
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks